Approval · Notice of Compliance 5631 · 1994

EFFEXOR: Notice of Compliance 5631

Issued July 18, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5631
Date: July 18, 1994
Company: Wyeth-Ayerst Canada Inc.St. Laurent, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Other
Therapeutic class: Antidepressant

Products in this notice

Brand	DIN	Status today
EFFEXOR	02103664	—
EFFEXOR	02103672	—
EFFEXOR	02103680	Cancelled Post Market
EFFEXOR	02103699	Cancelled Post Market
EFFEXOR	02103702	Cancelled Post Market
EFFEXOR	02103710	—

Medicinal ingredients

VENLAFAXINE HYDROCHLORIDE 12.5 MG per TAB
VENLAFAXINE HYDROCHLORIDE 37.5 MG per TAB
VENLAFAXINE HYDROCHLORIDE 75 MG per TAB
VENLAFAXINE HYDROCHLORIDE 100 MG per TAB
VENLAFAXINE HYDROCHLORIDE 50 MG per TAB
VENLAFAXINE HYDROCHLORIDE 25 MG per TAB